1-3 of 3
Martin Dyer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Functional Assay Using Etoposide Plus Nutlin 3, FISH and Mutational Analysis Detects Heterogeneity of ATM/p53 Pathway Alterations in CLL.

Giles Best, PhD, Anne Gardiner, BSc, Rachel Ibbotson, PhD, Aneela Majid, PhD, Renata Walewska, MD, Belinda Austen, MD, Tanja Stankovic, PhD, Martin Dyer, MD, David Graham Oscier, MD
Journal: Blood
Blood (2006) 108 (11): 2795.
https://doi.org/10.1182/blood.V108.11.2795.2795
Published: 2006
Journal Articles

Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies

Nelofer Syed, Paul Smith, Alexandra Sullivan, Lindsay C. Spender, Martin Dyer, Lorraine Karran, Jenny O'Nions, Martin Allday, Ingrid Hoffmann, Dorothy Crawford, Beverley Griffin, Paul J. Farrell, Tim Crook
Journal: Blood
Blood (2006) 107 (1): 250–256.
https://doi.org/10.1182/blood-2005-03-1194
Published: 2006
Journal Articles

A Retrospective Comparison between Cyclophosphamide (Cy) Followed by G-CSF, and Ifosfamide, Etoposide and Epirubicin (IVE) Plus G-CSF Mobilisation Regimes in Haematological Malignancies.

Miguel Ortin, MD, Sue Bricknell, Sheila Gribben, Lynn Stirrup, Martin Dyer, Ann Hunter, MD
Journal: Blood
Blood (2005) 106 (11): 5484.
https://doi.org/10.1182/blood.V106.11.5484.5484
Published: 2005